Summarized by Masters of Longevity from FDA - Drugs.
FDA approved asciminib for adults with newly diagnosed Ph+ CML.
Key Takeaways
- FDA granted accelerated approval to asciminib for adults.
- The approval is for newly diagnosed chronic phase Ph+ CML.
- Accelerated approval was granted and is not definitive evidence.
